Outset Medical, Inc. (OM)

NASDAQ: OM · IEX Real-Time Price · USD
2.220
+0.020 (0.91%)
At close: Mar 28, 2024, 4:00 PM
2.222
+0.002 (0.09%)
After-hours: Mar 28, 2024, 4:28 PM EDT

Company Description

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.

It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform.

The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015.

Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Outset Medical, Inc.
Outset Medical logo
Country United States
IPO Date Sep 15, 2020
Industry Medical Devices
Sector Healthcare
Employees 480
CEO Ms. Leslie L. Trigg

Contact Details

Address:
3052 Orchard Drive
San Jose, California 95134
United States
Phone 669-231-8200
Website outsetmedical.com

Stock Details

Ticker Symbol OM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $27.00
CIK Code 0001484612
CUSIP Number 690145107
ISIN Number US6901451079
Employer ID 20-0514392
SIC Code 3845

Key Executives

Name Position
Leslie L. Trigg President, Chief Executive Officer and Chairman
Nabeel Ahmed Chief Financial Officer
John L. Brottem General Counsel and Secretary
Marc Nash Senior Vice President of Operations and Research & Development
Jean-Olivier Racine Chief Technology Officer
James S. Mazzola Head of Investor Relations
Nicole Shannon Director of Marketing Communications
Dr. Michael Aragon M.D. Chief Medical Officer
Mark Gordon M.S. Chief Regulatory and Quality Officer

Latest SEC Filings

Date Type Title
Mar 15, 2024 144 Filing
Mar 13, 2024 8-K Current Report
Mar 1, 2024 144 Filing
Feb 22, 2024 S-8 Securities to be offered to employees in employee benefit plans
Feb 21, 2024 10-K Annual Report
Feb 21, 2024 8-K Current Report
Feb 15, 2024 144 Filing
Feb 15, 2024 144 Filing
Feb 15, 2024 144 Filing
Feb 15, 2024 144 Filing